MedPath
NMPA Approval

Moxifloxacin Hydrochloride Injection

国药准字H20193203

July 4, 2019

Drug Information

盐酸莫西沙星注射液

注射剂

20ml:0.4g(按C21H24FN3O4计)

化学药品

July 4, 2019

Company Information

Applicant Company

江苏省苏州市吴江区黎里镇芦墟国道路2688号

Manufacturing Company

江苏省泰州市扬子江南路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸莫西沙星注射液 - NMPA 批准文号 | MedPath